IFN-γ, controls the generation/activation of CD4+CD25+ regulatory T cells in antitumor immune response

被引:84
作者
Nishikawa, H
Kato, T
Tawara, I
Ikeda, H
Kuribayashi, K
Allen, PM
Schreiber, RD
Old, LJ
Shiku, H
机构
[1] Mie Univ, Sch Med, Dept Internal Med 2, Tsu, Mie 5148507, Japan
[2] Mie Univ, Sch Med, Dept Bioregulat, Tsu, Mie 5148507, Japan
[3] Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, St Louis, MO 63110 USA
[4] Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA
关键词
D O I
10.4049/jimmunol.175.7.4433
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunization with serological identification of Ags by recombinant expression cloning (SEREX)-defined self-Ags leads to generation/activation of CD4(+)CD25(+) regulatory T cells with suppressive activities and enhanced expression of Foxp3. This is associated with increased susceptibility to pulmonary metastasis following challenge with syngeneic tumor cells and enhanced development of 3-methylcholanthrene-induced primary tumors. In contrast, coimmunization with the same SEREX-defined self-Ags mixed with a CTL epitope results in augmented CTL activity and heightened resistance to pulmonary metastasis, both of which depend on CD4(+) Th cells. These active regulatory T cells and Th cells were derived from two distinct CD4(+) T cell subsets, CD4(+)CD25(+) T cells and CD4(+)CD25(-) T cells, respectively. In the present study, IFN-gamma was found to abrogate the generation/ activation of CD4(+)CD25(+) regulatory T cells by immunization with SEREX-defined self-Ag. CD4(+)CD25(+) T cells from these WN-gamma-treated mice failed to exhibit immunosuppressive activity as measured by 1) increased number of pulmonary metastasis, 2) enhanced development of 3-methylcholanthrene-induced primary tumors, 3) suppression of peptide-specific T cell proliferation, and 4) enhanced expression of Foxp3. The important role of IFN-gamma produced by CD8(+) T cells was shown in experiments demonstrating that CD4(+)CD25(+) T cells cotransferred with CD8(+) T cells from IFN-gamma mice, but not from wild-type BALB/c mice, became immunosuppressive and enhanced pulmonary metastasis when recipient animals were subsequently immunized with a SEREX-defined self-Ag and a CTL epitope. These findings support the idea that IFN-gamma regulates the generation/activation of CD4(+)CD25(+) regulatory T cells.
引用
收藏
页码:4433 / 4440
页数:8
相关论文
共 53 条
[11]   Adoptive-cell-transfer therapy for the treatment of patients with cancer [J].
Dudley, ME ;
Rosenberg, SA .
NATURE REVIEWS CANCER, 2003, 3 (09) :666-U2
[12]   T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells [J].
Fahlén, L ;
Read, S ;
Gorelik, L ;
Hurst, SD ;
Coffman, RL ;
Flavell, RA ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :737-746
[13]   Cutting edge:: TGF-β induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 [J].
Fantini, MC ;
Becker, C ;
Monteleone, G ;
Pallone, F ;
Galle, PR ;
Neurath, MF .
JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5149-5153
[14]   THE MOLECULAR CELL BIOLOGY OF INTERFERON-GAMMA AND ITS RECEPTOR [J].
FARRAR, MA ;
SCHREIBER, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 1993, 11 :571-611
[15]   Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003) [J].
Fontenot, Jason D. ;
Gavin, Marc A. ;
Rudensky, Alexander Y. .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :986-992
[16]   Eradication of established tumors by CD8+ T cell adoptive immunotherapy [J].
Hanson, HL ;
Donermeyer, DL ;
Ikeda, H ;
White, JM ;
Shankaran, V ;
Old, LJ ;
Shiku, H ;
Schreiber, RD ;
Allen, PM .
IMMUNITY, 2000, 13 (02) :265-276
[17]   Control of regulatory T cell development by the transcription factor Foxp3 [J].
Hori, S ;
Nomura, T ;
Sakaguchi, S .
SCIENCE, 2003, 299 (5609) :1057-1061
[18]   Mutated mitogen-activated protein kinase: A tumor rejection antigen of mouse sarcoma [J].
Ikeda, H ;
Ohta, N ;
Furukawa, K ;
Miyazaki, H ;
Wang, LJ ;
Furukawa, K ;
Kuribayashi, K ;
Old, LJ ;
Shiku, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) :6375-6379
[19]   The roles of IFNγ in protection against tumor development and cancer immunoediting [J].
Ikeda, H ;
Old, LJ ;
Schreiber, RD .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (02) :95-109
[20]   Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1:: Definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes [J].
Jäger, E ;
Chen, YT ;
Drijfhout, JW ;
Karbach, J ;
Ringhoffer, M ;
Jäger, D ;
Arand, M ;
Wada, H ;
Noguchi, Y ;
Stockert, E ;
Old, LJ ;
Knuth, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (02) :265-270